|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||
  Contact DermatitisVolume 25 Issue 1, Pages 30 - 34 Published Online: 11 Apr 2006 © 2010 John Wiley & Sons A/S
Abstract | References | Full Text: PDF (Size: 531K) | Related Articles | Citation Tracking  Cross-reactivity between sensitivity to thimerosal and photosensitivity to piroxicam in guinea pigs Copyright Munksgaard 1991 KEYWORDS drug eruption • photosensitivity • piroxicam • thimerosal • thiosalicylate • guinea pig sensitization • cross-sensitivity • Medicaments • nonsteroidal antiinflammatory drugs ABSTRACTPiroxicam (PXM) is a nansteroidal anti-inflammatory drug which may induce a photosensitive eruption shortly after administration. We examined whether animals sensitized to thimerosal developed a photosensitivity to PXM. Male Hartley strain guinea pigs were sensitized to thimerosal, thiosalicylate and PXM separately. The open patch test was used lo evaluate sensitization to each drug and cross-reactions between the drugs. Animals sensitized to thimerosal exhibited positive patch test thimerosal to thiosalicylate and positive path test reactions to PXM. Both those sensitized to thiosalicylate and to PXM showed positive patch test reactions to PXM. This study demonstrated that thimerosal induces cross-sensitivity to PXM in vivo and that the common active components among these compounds may be thiosalicylate. Accepted for publication 29 November 1990 | 
|
